NeuroBo Pharmaceuticals Inc
For the period ended Jun 7, 2024. Filed Apr 30, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jun 7, 2024 · Filed Apr 30, 2024
Contents
Cover page
Show cover page
DEF 14A 1 ny20026757x1_def14a.htm DEF 14A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
|---|
| ☒ | Definitive Proxy Statement |
|---|
| ☐ | Definitive Additional Materials |
|---|
| ☐ | Soliciting Material under §240.14a-12 |
|---|
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required |
|---|
| ☐ | Fee paid previously with preliminary materials |
|---|
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11 |
|---|
April 30, 2024
Dear Stockholder:
You are cordially invited to attend the 2024 annual meeting of stockholders (the “Annual Meeting”) of NeuroBo Pharmaceuticals, Inc. to be held on Friday, June 7, 2024 at 10:00 a.m. Eastern Time.
We invite you to attend the Annual Meeting and request that you vote on the proposals described in this proxy statement. However, you do not need to attend the Annual Meeting to vote your shares. Instead, you may vote by proxy, via the Internet, or by mail by following the instructions provided on the proxy card or voting instruction card, and we encourage you to vote before the Annual Meeting.
The enclosed Notice of 2024 Annual Meeting of Stockholders and the Proxy Statement contain details of the business to be conducted at the Annual Meeting and information you should consider when you vote your shares.
At the Annual Meeting, the agenda includes:
| • | Proposal 1 - to elect three Class II directors, each to serve a three-year term until the 2027 annual meeting of stockholders and until the election and qualification of his or her successor, or such director’s earlier death, resignation, or removal; |
|---|
| • | Proposal 2 - to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and |
|---|
| • | Proposal 3 - to approve an amendment to the NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan. |
|---|
The foregoing items of business are more fully described in the Proxy Statement accompanying this notice.
The Board of Directors unanimously recommends that you vote FOR the election of each director nominee and FOR Proposal 2 and Proposal 3. Your vote is important.
This year’s Annual Meeting will be held virtually through a live webcast. You will be able to attend the Annual Meeting online, vote electronically and submit your questions during the Annual Meeting by visiting www.virtualshareholdermeeting.com/NRBO2024 and entering your 16-digit control number included on your proxy card or on the instructions that accompanied your proxy materials. You will not be able to attend the Annual Meeting in person.
Even if you are planning on attending the Annual Meeting online, please promptly submit your proxy vote via the Internet or by completing, dating, signing and returning the enclosed proxy card or voting instruction card, so your shares will be represented at the Annual Meeting. Instructions on voting your shares are on the proxy materials you received for the Annual Meeting.
Sincerely,
Chair of the Board of Directors
545 Concord Avenue, Suite 210
NOTICE OF 2024 ANNUAL MEETING OF STOCKHOLDERS
To Be Held On June 7, 2024
To Our Stockholders:
NOTICE IS HEREBY GIVEN that the 2024 annual meeting of stockholders of NeuroBo Pharmaceuticals, Inc. will be held as a virtual meeting on June 7, 2024 at 10:00 a.m. Eastern Time. You will be able to attend the Annual Meeting online and vote electronically during the Annual Meeting by visiting www.virtualshareholdermeeting.com/NRBO2024 and entering your 16-digit control number included in your proxy card or in the instructions that accompanied your proxy materials. You will not be able to attend the Annual Meeting in person.
We are holding the meeting to consider and vote upon the following proposals, which are more fully described in the accompanying proxy statement:
| • | Proposal 1 - to elect three Class II directors, each to serve a three-year term until the 2027 annual meeting of stockholders and until the election and qualification of his or her successor, or such director’s earlier death, resignation, or removal; |
|---|
| • | Proposal 2 - to ratify the appointment of BDO USA, P.C. as our independent registered public accounting firm for the fiscal year ending December 31, 2024; and |
|---|
| • | Proposal 3 - to approve an amendment to the NeuroBo Pharmaceuticals, Inc. 2022 Equity Incentive Plan. |
|---|
In addition, stockholders may be asked to consider and vote upon such other business as may properly come before the meeting or any adjournment or postponement thereof.
The Board of Directors unanimously recommends that you vote FOR the election of each director nominee and FOR Proposal 2 and Proposal 3.
Only stockholders of record at the close of business on April 24, 2024 are entitled to notice of, and to vote at, the meeting and any adjournments thereof. For ten days prior to the meeting, a complete list of the stockholders entitled to vote at the meeting will be available for examination by any stockholder for any purpose relating to the meeting during ordinary business hours at our headquarters.
Your vote as a NeuroBo Pharmaceuticals, Inc. stockholder is very important. Each share of stock that you own represents one vote.
For questions regarding your stock ownership, you may contact Marshall Woodworth at (857)-299-1022 or via email at info@neurobopharma.com or, if you are a registered holder, our transfer agent, Equiniti Trust Company, LLC, by email at https://equiniti.com/us/ast-access or by phone at (800)-937-5449.
Whether or not you expect to virtually attend the meeting, we encourage you to read the proxy statement and vote through the Internet, or request, sign and return your proxy card or voting instruction card as soon as possible, so that your shares may be represented at the meeting. For specific instructions on how to vote your shares, please refer to the section entitled “Attending the Annual Meeting; Voting Instructions; Voting of Proxies” in the proxy statement.
By Order of the Board of Directors
Chair of the Board of Directors
Cambridge, Massachusetts
April 30, 2024
NEUROBO PHARMACEUTICALS, INC.
PROXY STATEMENT FOR 2024 ANNUAL MEETING OF STOCKHOLDERS
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.